Company: XTIA
Filing Date: 2025-04-18
Form Type: POS AM
Source: 0001213900-25-033058
Chunk: 16

Company: XTI Aerospace, Inc.
Filing Date: 2025-04-18
Form: POS AM
Chunk 16
---
 in Berlin Germany, and Eschborn, Germany, respectively.

Our telephone number is (800)
680-7412. Our Internet website is www.xtiaerospace.com. The information on, or that can be accessed through, our website is not part
of this prospectus, and you should not rely on any such information in making any investment decision relating to our securities.

<div align='center'>3</div>

THE OFFERING

| Issuer:                                                                      |     | XTI Aerospace, Inc.                                                                                                                                                                                                                                                                                                                                             |                                                                                                                  |
| Securities Offered:                                                          |     | This prospectus relates to:                                                                                                                                                                                                                                                                                                                                     |                                                                                                                  |
|                                                                              |     | ●                                                                                                                                                                                                                                                                                                                                                               | the offer, sale and issuance by the Company of up to 72,727                                                      
 shares of Common Stock upon exercise of the Placement Agent Warrants at an exercise price of $17.1875 per share; |
|                                                                              |     | ●                                                                                                                                                                                                                                                                                                                                                               | the offer, sale and issuance by the Company of up to 876,000 shares                                              
 of Common Stock upon exercise of the Pre-funded Warrants at an exercise price of $0.001 per share;               |
|                                                                              |     | ●                                                                                                                                                                                                                                                                                                                                                               | the offer, sale and issuance by the Company of up to 2,941,200                                                   
 shares of Common Stock upon exercise of the Common Warrants at an exercise price of $1.36 per share; and         |
|                                                                              |     | ●                                                                                                                                                                                                                                                                                                                                                               | the offer, sale and issuance by the Company of up to 147,060                                                     
 shares of Common Stock upon exercise of the Representative’s Warrants at an exercise price of $1.70 per share.   |
| Shares of Common Stock Outstanding Assuming the Exercise of All Warrants(1): |     | 9,824,527                                                                                                                                                                                                                                                                                                                                                       
 shares of Common Stock                                                                                                                                                                                                                                                                                                                                          |                                                                                                                  |
| Use of Proceeds                                                              |     | We intend to use the net proceeds from the exercise of the Warrants for working capital and other general corporate purposes. There can be no assurance that any Warrant holder will exercise Warrants, especially since, as of the date of this prospectus, none of the Warrants, other than the Pre-funded Warrants, are in-the-money. See “Use of Proceeds.” |                                                                                                                  |
| Risk Factors                                                                 |     | See “Risk Factors” incorporated by reference into this                                                                                                                                                                                                                                                                                                          
 prospectus for a discussion of